Y070-3030 Screening compound: (5Z)-5-{[5-(2,3-dichlorophenyl)furan-2-yl]methylidene}-2-[(1E)-2-phenylethenyl]-5H,6H-[1,2,4]triazolo[3,2-b][1,3]thiazol-6-one

Y070-3030 Screening compound: (5Z)-5-{[5-(2,3-dichlorophenyl)furan-2-yl]methylidene}-2-[(1E)-2-phenylethenyl]-5H,6H-[1,2,4]triazolo[3,2-b][1,3]thiazol-6-one
Y070-3030 Screening compound: (5Z)-5-{[5-(2,3-dichlorophenyl)furan-2-yl]methylidene}-2-[(1E)-2-phenylethenyl]-5H,6H-[1,2,4]triazolo[3,2-b][1,3]thiazol-6-one alternative view

Chemical Structure Depiction of ChemDiv screening compound Y070-3030
(5Z)-5-{[5-(2,3-dichlorophenyl)furan-2-yl]methylidene}-2-[(1E)-2-phenylethenyl]-5H,6H-[1,2,4]triazolo[3,2-b][1,3]thiazol-6-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y070-3030

Molecular Formula

C23H13Cl2N3O2S (C23 H13 Cl2 N3 O2 S)

Compound Name

(5Z)-5-{[5-(2,3-dichlorophenyl)furan-2-yl]methylidene}-2-[(1E)-2-phenylethenyl]-5H,6H-[1,2,4]triazolo[3,2-b][1,3]thiazol-6-one

IUPAC name

(5Z)-5-{[5-(23-dichlorophenyl)furan-2-yl]methylidene}-2-[(1E)-2-phenylethenyl]-5H6H-[124]triazolo[32-b][13]thiazol-6-one

SMILES

O=C1n2nc(/C=C/c3ccccc3)nc2S/C1=C\c1ccc(-c2cccc(Cl)c2Cl)o1

InChI

InChI=1S/C23H13Cl2N3O2S/c24-17-8-4-7-16(21(17)25)18-11-10-15(30-18)13-19-22(29)28-23(31-19)26-20(27-28)12-9-14-5-2-1-3-6-14/h1-13H

InChI Key

LNAPKYUZCXSLBN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD18076139

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

466.35

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.614

Distribution Coefficient, logD

6.614

Water Solubility, LogSw

-6.54

Polar Surface Area

45.756

Acid Dissociation Constant (pKa)

14.00

Base Dissociation Constant (pKb)

-3.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

Y070-3030 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with Y070-3030 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y070-3030?
Check Price and Availability of Y070-3030, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y070-3030 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y070-3030
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y070-3030
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y070-3030 available by request